Han River Partners

All recorded activity

Rounds participated in: 1
Confirmed lead rounds: 0
New companies: 1
Funding in participating rounds: $10M

By stage

Undisclosed1

By primary sector

Healthtech1

By country

South Korea1

Rounds

1 in all activity

Sep 21

ImpriMed

A precision-oncology service that tests live cancer cells against drugs and uses clinical data to predict which treatments may work best for each patient.

$10MSeries A2 bridge

Participant